Header Logo

Connection

CELESTINE TUNG to Ovarian Neoplasms

Back to Details
This is a "connection" page, showing publications CELESTINE TUNG has written about Ovarian Neoplasms.
CELESTINE TUNG
Connection Strength
0.669
Ovarian Neoplasms
  1. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol. 2009 Sep; 22(9):1243-50.
    View in: PubMed
    Score: 0.244
  2. Biomarker discovery in ovarian cancer. Womens Health (Lond). 2008 Jan; 4:27-40.
    View in: PubMed
    Score: 0.221
  3. Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer. Gynecol Oncol. 2017 10; 147(1):41-46.
    View in: PubMed
    Score: 0.107
  4. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am J Surg Pathol. 2011 Jun; 35(6):904-12.
    View in: PubMed
    Score: 0.070
  5. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy. J Minim Invasive Gynecol. 2017 Jul - Aug; 24(5):772-776.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.